Search Results - "Chopitea, A"

Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery by Arredondo, J., Baixauli, J., Pastor, C., Chopitea, A., Sola, J. J., González, I., A-Cienfuegos, J., Martínez, P., Rodriguez, J., Hernández-Lizoain, J. L.

“…Purpose Neoadjuvant chemotherapy is being actively tested as an emerging alternative for the treatment of locally advanced colon cancer (LACC) patients,…”
Get full text

Successful desensitization to oxaliplatin after a single initial dose of omalizumab in a patient with elevated IgE levels by Penella, J, Quan, P, Carvallo, A, Chopitea, A, Sala, P, García Del Barrio, M A, Gastaminza, G, Goikoetxea, M J

“…Omalizumab, an anti-IgE monoclonal antibody, is used as an adjuvant in hymenoptera venom immunotherapy and in induction of oral tolerance in food allergy. In…”
Get full text

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis by Zarate, R, Rodríguez, J, Bandres, E, Patiño-Garcia, A, Ponz-Sarvise, M, Viudez, A, Ramirez, N, Bitarte, N, Chopitea, A, Gacía-Foncillas, J

“…Background: A dose-finding study was performed to evaluate the dose-limiting toxicity (DLT), maximum-tolerated dose (MTD) and the recommended dose (RD) of…”
Get full text

Combining chemotherapy and targeted therapies in metastatic colorectal cancer by J Rodriguez R Zarate E Bandres A Viudez, A Chopitea, J Garcia-Foncillas I GiI-Bazo

“…Colorectal cancer remains one of the major causes of cancer death worldwide. During the past years, the development of new effective treatment options has led…”
Get full text

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients by Abajo, A, Rodriguez, J, Bitarte, N, Zarate, R, Boni, V, Ponz, M, Chopitea, A, Bandres, E, Garcia-Foncillas, J

“…Background: To determine the dose-limiting toxicity (DLT), maximum tolerated dose, recommended dose (RD) and preliminary evidence of activity of escalating…”
Get full text

Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer by Arredondo, J., Pastor, C., Baixauli, J., Rodríguez, J., González, I., Vigil, C., Chopitea, A., Hernández-Lizoáin, J. L.

“…Aim Preoperative chemotherapy followed by radical surgery is an attractive treatment for locally advanced colon cancer (LACC) given the promising results of…”
Get full text

Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience by Ceniceros, L., Chopitea, A., Pardo, F., Rotellar, F., Arbea, L., Sola, J. J., Subtil, J. C., Sangro, B., Benito, A., Hernández-Lizoain, J. L., Rodríguez, J.

“…Background Synchronous liver metastases (LM) from gastric (GC) or esophagogastric junction (EGJ) adenocarcinoma are a rare events. Several trials have…”
Get full text

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new? by Ponz-Sarvisé, M, Rodríguez, J, Viudez, A, Chopitea, A, Calvo, A, García-Foncillas, J, Gil-Bazo, I

“…Colorectal cancer constitutes one of the most common malignancies and the second leading cause of death from cancer in the western world representing one…”
Get full text

Association of RRM1 –37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy by Rodriguez, J, Boni, V, Hernández, A, Bitarte, N, Zarate, R, Ponz-Sarvisé, M, Chopitea, A, Bandres, E, Garcia-Foncillas, J

“…Abstract Background To investigate whether single nucleotide polymorphisms (SNPs) in gemcitabine (GMB) metabolism genes were associated with clinical outcome…”
Get full text

Four-week Neoadjuvant Intensity Modulated Radiation Therapy With Concurrent Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer Patients: A Single Institution Experience With Long-term Follow-up by Arbea, L, Moreno, M, Rodriguez, J, Hernandez, J, Sola, I, Subtil, J, Chopitea, A, Martinez-Monge, R, Cambeiro, M, Aristu, J

Get full text

Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma by González-Cao, M, Viteri, S, Díaz-Lagares, A, González, A, Redondo, P, Nieto, Y, Espinós, J, Chopitea, A, Ponz, M, Martín-Algarra, S

“…Pretreated advanced melanoma is a poor prognosis scenario with few, if any, active therapeutic options. The antibody against vascular endothelial growth…”
Get more information

Epidermal growth factor receptor inhibitors in colorectal cancer treatment： What＇s new by M Ponz-Sarvise J Rodriguez A Viudez A Chopitea A Calvo J Garcia-Foncillas I Gil-Bazo

“…Colorectal cancer constitutes one of the most common malignancies and the second leading cause of death from cancer in the western world representing one…”
Get full text

Preoperative Chemoradiation in Gastric Cancer: Feasibility, Patterns of Response, and Disease-free Survival (DFS) by Diaz-Gonzalez, J.A, Ciervide, R, Gaztañaga, M, San Miguel, I, Hernandez, J.L, Sola, J, Arbea, L, Aristu, J, Chopitea, A, Rodriguez, J

Get full text

CAPOX-IMRT in locally advanced rectal cancer: Long-term follow-up by Arbea, L, Moreno, M, Rodríguez, J, Hernández, J, Sola, I, Subtil, J, Chopitea, A, Martínez-monge, R, Cambeiro, M, Aristu, J

Get full text

Triple drug docetaxel-based neoadjuvant treatment in gastric cancer: Long-term results by Martin Romano, P, Rodriguez, J, Diaz-gonzalez, J, Chopitea, A, Garzon, C, Aristu, J, Castañon, E, Fusco, J, Zubiri, L, Rodriguez-ruiz, M, Olarte, A, Arbea Moreno, L

Get full text

Tumor Response and Disease Free Survival (DFS) after Preoperative Treatment in Gastric Cancer Followed by Surgery: Chemotherapy (Ch) vs. Chemoradiotherapy (ChRT) by Diaz-Gonzalez, J.A, Fakih, N, Martin, P, Rodriguez, J, Aristu, J, Arbea, L, Viudez, A, Chopitea, A, Hernandez-Lizoain, J.L, Garcia-Foncillas, J

Get full text

Neoadjuvant Chemotherapy (NCT) and Chemoradiotherapy (CRT) in Locally Advanced Pancreatic Cancer: Clinical and Pathologic Downstaging by Diaz-Gonzalez, J.A, Chopitea, A, Aristu, J.J, Pardo, F, Arbea, L, Rodriguez, J, Viudez, A, Rotellar, F, Montiel, C, Garcia-Foncillas, J

Get full text

Chemotherapy after immunotherapy failure in patients with advanced gastrointestinal tumors by Baraibar Argota, I., Martin Romano, P., Sanmamed, M.F., Rodríguez Ruiz, M., Melero, I., Resano, L., Chopitea Ortega, A., Ponz-Sarvisé, M., Castanon Alvarez, E.

Get full text

Previous immunotherapy treatments may improve tumor responses with subsequent chemotherapy regimens by Baraibar Argota, I., Martin-Romano, P., Sanmamed, M.F., Rodriguez-Ruiz, M., Pérez-Gracia, J.L., Gil-Bazo, I., Melero, I., Resano, L., Chopitea Ortega, A., Rodriguez, J., Aramendia, J.M., Gardeazabal, I., Ceniceros, L., Sala Elarre, P., Ponz-Sarvisé, M., Castanon Alvarez, E.

Get full text

Development of the National Kidney Transplantation Program in Uruguay by González-Martínez, F, Orihuela, S, Alvarez, I, Dibello, N, Curi, L, Nin, M, Wimber, E, Mizraji, R, Bengochea, M, González, G, Manzo, L, Toledo, R, Silva, W, Chopitea, Á, Lopez, D, Balboa, O, Porto, D, Noboa, O

“…Abstract The first kidney transplantation (KT) in Uruguay was performed in 1969. We report the rates of KT and survival of patients and grafts up to December…”
Get full text